They should sell anything with value, if any at this point. I dont think AE37 is worth what they claim (300m). Regardless of outcome this Management Team is weak, I question experience and credibility. Any pps increase will be met by sellers because of future risk .Im sure Covid is the main "attraction" right now and if that doesnt work out it will be a good excuse "current conditions" for company failure!! Looks like a lot of buffoonery for now !!
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links